2021³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥: The Role of bactreria in urology : 2021-08-21 ±³À°ÀÏÀÚ : 2021-08-21
±³À°Àå¼Ò : ¹é¹ü ±è±¸±â³ä°ü ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ :
2021³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥: The Role of bactreria in urology ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ
´ã´çÀÚ : °¡¿Â
¿¬¶ôó : 02-2039-7988
À̸ÞÀÏ :
gaonpco@gaonpco ±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 55ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í ȸ¿ø (¿¬È¸ºñ³³ºÎ) : ¹«·á ȸ¿ø (¿¬È¸ºñ ¹Ì³³ºÎ): 10,000¿ø ºñȸ¿ø: 100,000¿ø Àü°øÀÇ ¹× °£È£»ç: ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-21 ¹é¹ü ±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:00~10:15 BCG infection following intravesical instillation for bladder cancer in the COVID-19 era ( Management of Toxicity and Side Effects) Á¤ÀçÈï(¿¬¼¼¿øÁÖÀÇ´ë)
±³À°½Ã°£ 08-21 ¹é¹ü ±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:15~10:30 BCG versus COVID-19: impact on urology (e.g. COVID-19 vaccination & BCG instillation, BCG vaccine against COVID-19) ÃÖÁøºÀ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 08-21 ¹é¹ü ±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:30~10:50 Panel Discussion ÀåÀÎÈ£(Áß¾ÓÀÇ´ë)
ÈÞ½Ä 08-21 10:50~11:10 Coffee Break ()
±³À°½Ã°£ 08-21 The-KÈ£ÅÚ ¼¿ï ±Ý° AȦ (º°°ü ¿¡ºñ´º 2Ãþ) 11:10~11:25 Effects of Antibiotic Treatment on Gut Microbiota & genitourinary disease ¾çÈñÁ¶(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 08-21 The-KÈ£ÅÚ ¼¿ï ±Ý° AȦ (º°°ü ¿¡ºñ´º 2Ãþ) 11:25~11:40 How to Overcome Negative Impacts of dysbiosis (NONTRADITIONAL ANTIMICROBIAL APPROACHES, e.g. FMT, probiotics) ¹è»ó¶ô(°¡Å縯ÀÇ´ë)
Åä·Ð 08-21 The-KÈ£ÅÚ ¼¿ï ±Ý° AȦ (º°°ü ¿¡ºñ´º 2Ãþ) 11:40~11:55 Panel Discussion ÃÖÇö¼·(°¡Å縯ÀÇ´ë)
½Ä»ç 08-21 11:55~12:40 Á¡½É½Ä»ç ()
±³À°½Ã°£ 08-21 The-KÈ£ÅÚ ¼¿ï ±Ý° AȦ (º°°ü ¿¡ºñ´º 2Ãþ) 12:40~12:55 2021 EAU Urological Infections Guidelines (Focus on Recent changes : e.g. CA-UTI, HPV in male, prostate biopsy) Á¤°æÁø(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 08-21 The-KÈ£ÅÚ ¼¿ï ±Ý° AȦ (º°°ü ¿¡ºñ´º 2Ãþ) 12:55~13:10 Recent Update of guidelines on urinary tract infections in children (~ updated 2021 EAU/ESPU guidelines ) Á¤Àç¹Î(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 08-21 The-KÈ£ÅÚ ¼¿ï ±Ý° AȦ (º°°ü ¿¡ºñ´º 2Ãþ) 13:10~13:25 Recurrent Uncomplicated Urinary Tract Infections in Women (e.g. AUA/CUA/SUFU Guideline, EAU Guideline) ½ÅÁÖÇö(Ãæ³²ÀÇ´ë)
Åä·Ð 08-21 The-KÈ£ÅÚ ¼¿ï ±Ý° AȦ (º°°ü ¿¡ºñ´º 2Ãþ) 13:25~13:40 Panel Discussion ±èµÎ»ó(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 08-21 The-KÈ£ÅÚ ¼¿ï ±Ý° AȦ (º°°ü ¿¡ºñ´º 2Ãþ) 13:40~14:00 Antimicrobial Stewardship and Urinary Tract Infections °Ã¶ÀÎ(¼º±Õ°üÀÇ´ë)
ÈÞ½Ä 08-21 14:00~14:10 Coffee Break ()
±³À°½Ã°£ 08-21 The-KÈ£ÅÚ ¼¿ï ±Ý° BȦ (º°°ü ¿¡ºñ´º 2Ãþ) 14:10~14:20 STI guideline ÃÖÁøºÀ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 08-21 The-KÈ£ÅÚ ¼¿ï ±Ý° BȦ (º°°ü ¿¡ºñ´º 2Ãþ) 14:20~14:30 History of KAUTII À̼ҿ¬(ÇѾçÀÇ´ë)
±³À°½Ã°£ 08-21 The-KÈ£ÅÚ ¼¿ï ±Ý° BȦ (º°°ü ¿¡ºñ´º 2Ãþ) 14:30~14:40 Text book of KAUTII (2nd edition) ÀÌÁ¤¿ì(°æÈñÀÇ´ë)
±³À°½Ã°£ 08-21 The-KÈ£ÅÚ ¼¿ï ±Ý° BȦ (º°°ü ¿¡ºñ´º 2Ãþ) 14:40~14:50 Guideline for antibiotic use ¾ç½Â¿Á(Áß¾Óº¸Èƺ´¿ø)
±³À°½Ã°£ 08-21 The-KÈ£ÅÚ ¼¿ï ±Ý° BȦ (º°°ü ¿¡ºñ´º 2Ãþ) 14:50~15:00 º¸°ÇÀÇ·áÀÎ ¹× ¿ä¾çº¸È£»ç¸¦ À§ÇÑ ¹è´¢°ü¸® ¼³¸í¼ °³¹ß Á¤ÀçÈï(¿¬¼¼¿øÁÖÀÇ´ë)
Åä·Ð 08-21 The-KÈ£ÅÚ ¼¿ï ±Ý° BȦ (º°°ü ¿¡ºñ´º 2Ãþ) 15:00~15:10 Panel Discussion ÃÖ¼¼¿µ(Áß¾ÓÀÇ´ë)